This preprint is under consideration at BMC Urology. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Ping Ao
Department of Urology, The First Affiliated Hospital of Wannan Medical College
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: To evaluate the efficacy of flexible ureteroscopic lithotripsy (FURSL) based on the concept of enhanced recovery after surgery (ERAS).
Methods: 435 patients with upper urinary calculi between 2017-2020 were retrospectively analysed and assigned to ERAS group (ERAS management) and control group (traditional management). Operative time, postoperative ambulation time, postoperative hospital stay, total cost of hospitalization, postoperative complications and stone removal were compared.
Results: 427 cases were successfully performed FURSL procedure with 4 cases of ERAS group (n = 216) and 4 cases of control group (n = 219) failed respectively. No postoperative complications occurred in either group except for fever and hematuria. There were no significant difference in postoperative fever and stone removal between the two groups (all p > 0.05). The patients in ERAS group had shorter operative time, shorter postoperative ambulation time, less postoperative severe hematuria, shorter postoperative hospital stay and lower total cost of hospitalization than those in control group (all p < 0.05).
Conclusions: FURSL based on the concept of ERAS for the treatment of upper urinary tract calculi is safe and reliable, with rapid postoperative recovery, low cost of hospitalization and worthy of clinical promotion.
Keywords
Flexible ureteroscopy, Lithotripsy, Laser, Enhanced recovery after surgery, ERAS
This preprint is available for download as a PDF.
No competing interests reported.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version 1
Posted 04 Mar, 2021
No community comments so far
Review #2 received
Received 07 Mar, 2021
Review #1 received
Received 07 Mar, 2021
Review #3 received
Received 07 Mar, 2021
Reviewer #17 agreed
On 01 Mar, 2021
Reviewer #3 agreed
On 01 Mar, 2021
Reviewer #15 agreed
On 01 Mar, 2021
Reviewer #1 agreed
On 01 Mar, 2021
Reviewer #2 agreed
On 01 Mar, 2021
Reviewer #4 agreed
On 01 Mar, 2021
Reviewer #16 agreed
On 01 Mar, 2021
Review #21 received
Received 28 Feb, 2021
Review #7 received
Received 28 Feb, 2021
Review #4 received
Received 28 Feb, 2021
Review #19 received
Received 28 Feb, 2021
Review #5 received
Received 28 Feb, 2021
Review #6 received
Received 28 Feb, 2021
Review #17 received
Received 28 Feb, 2021
Review #8 received
Received 28 Feb, 2021
Review #12 received
Received 28 Feb, 2021
Review #18 received
Received 28 Feb, 2021
Review #20 received
Received 28 Feb, 2021
Review #11 received
Received 28 Feb, 2021
Review #13 received
Received 28 Feb, 2021
Review #10 received
Received 28 Feb, 2021
Review #22 received
Received 28 Feb, 2021
Review #9 received
Received 28 Feb, 2021
Reviewer #22 agreed
On 28 Feb, 2021
Reviewer #8 agreed
On 28 Feb, 2021
Reviewer #5 agreed
On 28 Feb, 2021
Reviewer #20 agreed
On 28 Feb, 2021
Reviewer #6 agreed
On 28 Feb, 2021
Reviewer #7 agreed
On 28 Feb, 2021
Reviewer #18 agreed
On 28 Feb, 2021
Reviewer #9 agreed
On 28 Feb, 2021
Reviewer #13 agreed
On 28 Feb, 2021
Reviewer #19 agreed
On 28 Feb, 2021
Reviewer #21 agreed
On 28 Feb, 2021
Reviewer #12 agreed
On 28 Feb, 2021
Reviewer #14 agreed
On 28 Feb, 2021
Reviewer #11 agreed
On 28 Feb, 2021
Reviewer #23 agreed
On 28 Feb, 2021
Reviewer #10 agreed
On 28 Feb, 2021
Reviewers invited
Invitations sent on 28 Feb, 2021
Editor assigned
On 28 Feb, 2021
Editor invited
On 28 Feb, 2021
Submission checks complete
On 28 Feb, 2021
First submitted
On 24 Feb, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Urology & Nephrology
Learn more about our company.
This preprint is under consideration at BMC Urology. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Ping Ao
Department of Urology, The First Affiliated Hospital of Wannan Medical College
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version 1
Posted 04 Mar, 2021
No community comments so far
Review #2 received
Received 07 Mar, 2021
Review #1 received
Received 07 Mar, 2021
Review #3 received
Received 07 Mar, 2021
Reviewer #17 agreed
On 01 Mar, 2021
Reviewer #3 agreed
On 01 Mar, 2021
Reviewer #15 agreed
On 01 Mar, 2021
Reviewer #1 agreed
On 01 Mar, 2021
Reviewer #2 agreed
On 01 Mar, 2021
Reviewer #4 agreed
On 01 Mar, 2021
Reviewer #16 agreed
On 01 Mar, 2021
Review #21 received
Received 28 Feb, 2021
Review #7 received
Received 28 Feb, 2021
Review #4 received
Received 28 Feb, 2021
Review #19 received
Received 28 Feb, 2021
Review #5 received
Received 28 Feb, 2021
Review #6 received
Received 28 Feb, 2021
Review #17 received
Received 28 Feb, 2021
Review #8 received
Received 28 Feb, 2021
Review #12 received
Received 28 Feb, 2021
Review #18 received
Received 28 Feb, 2021
Review #20 received
Received 28 Feb, 2021
Review #11 received
Received 28 Feb, 2021
Review #13 received
Received 28 Feb, 2021
Review #10 received
Received 28 Feb, 2021
Review #22 received
Received 28 Feb, 2021
Review #9 received
Received 28 Feb, 2021
Reviewer #22 agreed
On 28 Feb, 2021
Reviewer #8 agreed
On 28 Feb, 2021
Reviewer #5 agreed
On 28 Feb, 2021
Reviewer #20 agreed
On 28 Feb, 2021
Reviewer #6 agreed
On 28 Feb, 2021
Reviewer #7 agreed
On 28 Feb, 2021
Reviewer #18 agreed
On 28 Feb, 2021
Reviewer #9 agreed
On 28 Feb, 2021
Reviewer #13 agreed
On 28 Feb, 2021
Reviewer #19 agreed
On 28 Feb, 2021
Reviewer #21 agreed
On 28 Feb, 2021
Reviewer #12 agreed
On 28 Feb, 2021
Reviewer #14 agreed
On 28 Feb, 2021
Reviewer #11 agreed
On 28 Feb, 2021
Reviewer #23 agreed
On 28 Feb, 2021
Reviewer #10 agreed
On 28 Feb, 2021
Reviewers invited
Invitations sent on 28 Feb, 2021
Editor assigned
On 28 Feb, 2021
Editor invited
On 28 Feb, 2021
Submission checks complete
On 28 Feb, 2021
First submitted
On 24 Feb, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Urology & Nephrology
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: To evaluate the efficacy of flexible ureteroscopic lithotripsy (FURSL) based on the concept of enhanced recovery after surgery (ERAS).
Methods: 435 patients with upper urinary calculi between 2017-2020 were retrospectively analysed and assigned to ERAS group (ERAS management) and control group (traditional management). Operative time, postoperative ambulation time, postoperative hospital stay, total cost of hospitalization, postoperative complications and stone removal were compared.
Results: 427 cases were successfully performed FURSL procedure with 4 cases of ERAS group (n = 216) and 4 cases of control group (n = 219) failed respectively. No postoperative complications occurred in either group except for fever and hematuria. There were no significant difference in postoperative fever and stone removal between the two groups (all p > 0.05). The patients in ERAS group had shorter operative time, shorter postoperative ambulation time, less postoperative severe hematuria, shorter postoperative hospital stay and lower total cost of hospitalization than those in control group (all p < 0.05).
Conclusions: FURSL based on the concept of ERAS for the treatment of upper urinary tract calculi is safe and reliable, with rapid postoperative recovery, low cost of hospitalization and worthy of clinical promotion.
This preprint is available for download as a PDF.
Loading...